Adaptyx has demonstrated the first continuous wearable measurement of free cortisol across multiple days in humans, capturing real-time hormone dynamics rather than isolated snapshots. This shift from point-in-time testing to continuous monitoring addresses a fundamental gap in understanding how cortisol rhythms — not just absolute levels — drive metabolic health, glucose regulation, and stress resilience.
Key Points
- Wearable accurately tracks cortisol changes against blood measurements
- Captures cortisol awakening response and circadian dips missed by conventional testing
- Dysregulated cortisol rhythms precede metabolic disease and poor sleep
Longevity Analysis
Cortisol dysrhythmia represents a measurable precursor to conditions that accelerate aging — type 2 diabetes, hypertension, poor recovery, and disrupted sleep architecture. Understanding when cortisol rises, falls, or desynchronizes from the circadian clock allows for earlier detection and intervention before pathology becomes entrenched. The ability to track hormone dynamics in real time shifts clinical assessment from retrospective diagnosis toward prospective pattern recognition, enabling targeted modifications to sleep, stress exposure, movement, and recovery practices before compensation mechanisms begin to fail.
Original published by Longevity.Technology, by Kyle Umipig.